Table 1.
Gene | CTCF | CNOT1 | VPS4A | GNAO1 | VAC14 | RSPRY1 | CYLD | IRX5 | ZNF423 | |||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
OMIM | 604,167 | 604,917 | 609,982 | 139,311 | 604,632 | 616,585 | 605,018 | 606,195 | 604,557 | |||||||
Cytogenetic | 16q22.1 | 16q21 | 16q22.1 | 16q13 | 16q22.1-q22.2 | 16q13 | 16q12.1 | 16q12.2 | 16q12.1 | |||||||
Inheritance | AD | AD; | AD | AD | AD; | AD | AR | AR | AD | AR | AD, AR; | AD, AR | ||||
Phenotype | Intellectual developmental disorder, autosomal dominant 21 | Holoprosencephaly 12, with or without pancreatic agenesis; | Vissers-Bodmer syndrome | CIMDAG syndrome | Developmental and epileptic encephalopathy 17 | Neurodevelopmental disorder with involuntary movements | Striatonigral degeneration, childhood-onset | Spondyloepimetaphyseal dysplasia | Faden-Alkuraya type | Frontotemporal dementia and/or amyotrophic lateral sclerosis 8 | Brooke-Spiegler syndrome | Cylindromatosis, familial | Trichoepithelioma, multiple familial, 1 | Hamamy syndrome | Joubert syndrome 19 | Nephronophthisis 14 |
Dysfunction of Gene Product | DNA-binding transcription factor; regulating gene expression and chromatin organization | the central scaffolding protein (in)directly binding to all CCR4-NOT partners | critical enzyme regulating endosomal sorting complexes required for transport (ESCRT) function | encodes Gαo, the α subunit of Go; are involved as modulators or transducers in various transmembrane signaling systems | a trimolecular complex that tightly regulates the level of phosphatidylinositol 3,5-bisphosphate [PI (3,5) P2] | encodes a hypothetical RING and SPRY domain-containing protein | a ubiquitin hydrolase; specifically cleaves ‘Lys-63’- and linear ‘Met-1’-linked polyubiquitin chains and is involved in NF-kappa-B activation and TNF-alpha-induced necroptosis | Involved in craniofacial and gonadal development; the regulation of human ventricular depolarization and cardiac electrical conduction | a central role in BMP signaling and olfactory neurogenesis | |||||||
a | 1 | 1 | 1 | 0.99 | 0.99 | 0.99 | 0.98 | 0.98 | 0.96 |
agnomAD (v2.1.1) pTriplo, pTriplo scores ≥ 0.94 indicate that the average effect sizes of duplications are as strong as the loss-of-function of genes known to be constrained against protein truncating variants [9]